Chablani, P. V., Khaki, A. R., Tawagi, K., Grivas, P., Hoffman-Censits, J., Galsky, M. D., Gupta, S., Koshkin, V. S., Plimack, E. R., Rosenberg, J. E., O'Donnell, P. H. (2025). Survey-based study of treatment sequencing after first-line (1L) enfortumab vedotin/pembrolizumab (EVP) in the evolving landscape of locally advanced/metastatic (la/m) urothelial cancer (UC).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.5_suppl.770